-
1
-
-
0001822571
-
Global impact of hepatitis A virus infection: Changing patterns
-
Hollinger FB, Lemon SM, Margolis HS, eds. Baltimore, Williams and Wilkins
-
Hadler SC. Global impact of hepatitis A virus infection: changing patterns. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral Hepatitis and Liver Disease. Baltimore, Williams and Wilkins, 1991; 14-20
-
(1991)
Viral Hepatitis and Liver Disease
, pp. 14-20
-
-
Hadler, S.C.1
-
2
-
-
0026472631
-
Epidemiological patterns of hepatitis A in different parts of the world
-
Gust ID. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine 1992; 10: S56-S62
-
(1992)
Vaccine
, vol.10
-
-
Gust, I.D.1
-
3
-
-
0026483854
-
Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: Rationale and summary of findings
-
Andre F, D'Hondt E, Delem A, Safary A. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings. Vaccine 1992; 10: S160-S168
-
(1992)
Vaccine
, vol.10
-
-
Andre, F.1
D'Hondt, E.2
Delem, A.3
Safary, A.4
-
4
-
-
0026556244
-
Clinical trial with inactivated hepatitis vaccine and recommendations for its use
-
Tilzey AJ, Palmer SJ, Barrow S et al. Clinical trial with inactivated hepatitis vaccine and recommendations for its use. Br Med J 1992; 304: 1272-1276
-
(1992)
Br. Med. J
, vol.304
, pp. 1272-1276
-
-
Tilzey, A.J.1
Palmer, S.J.2
Barrow, S.3
-
5
-
-
0027325769
-
Active immunization against hepatitis A. Comparison of various immunization schedules
-
Muller R, Bock HL, Clemens R, Jilg W. Active immunization against hepatitis A. Comparison of various immunization schedules. Dtsch Med Wochenschr 1993; 118: 1101-1104
-
(1993)
Dtsch. Med. Wochenschr
, vol.118
, pp. 1101-1104
-
-
Muller, R.1
Bock, H.L.2
Clemens, R.3
Jilg, W.4
-
6
-
-
0026643021
-
A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children
-
Werzberger A, Mensch B, Kuter B et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992; 327: 453-457
-
(1992)
N. Engl. J. Med
, vol.327
, pp. 453-457
-
-
Werzberger, A.1
Mensch, B.2
Kuter, B.3
-
7
-
-
0028556678
-
Single dose inactivate hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicity
-
Van Damme P, Mathei C, Thoelen S et al. Single dose inactivate hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity. J Med Virol 1994; 44: 435-441
-
(1994)
J. Med. Virol
, vol.44
, pp. 435-441
-
-
Van Damme, P.1
Mathei, C.2
Thoelen, S.3
-
8
-
-
0031021442
-
Vaccines to prevent viral hepatitis
-
Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med 1997; 336: 196-204
-
(1997)
N. Engl. J. Med
, vol.336
, pp. 196-204
-
-
Lemon, S.M.1
Thomas, D.L.2
-
9
-
-
0028300243
-
Immune response after hepatitis A vaccination in hemodialysis patients: Comparison with hepatitis B vaccination
-
Kuramoto I, Fujiyama S, Matsushita K, Sato T. Immune response after hepatitis A vaccination in hemodialysis patients: Comparison with hepatitis B vaccination. J Gastroenterol Hepatol 1994; 9: 228-231
-
(1994)
J. Gastroenterol. Hepatol
, vol.9
, pp. 228-231
-
-
Kuramoto, I.1
Fujiyama, S.2
Matsushita, K.3
Sato, T.4
-
10
-
-
0035957964
-
Recommendations for preventing transmission of infections among chronic hemodialysis patients
-
Centers for Disease Control and Prevention (CDC) 27 April RR-5
-
Centers for Disease Control and Prevention (CDC) Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR, 27 April 2001 50 RR-5
-
(2001)
MMWR
, vol.50
-
-
-
11
-
-
0032801079
-
Vaccination against hepatitis A and B in chronic liver disease
-
Keeffe EB. Vaccination against hepatitis A and B in chronic liver disease. Viral Hepatitis Rev 1999; 5: 77-88
-
(1999)
Viral Hepatitis Rev
, vol.5
, pp. 77-88
-
-
Keeffe, E.B.1
-
13
-
-
0029761219
-
Inactivated hepatitis A vaccine (HM175 strain): A preliminary review of its immunogenicity, protective potential and tolerability in at-risk patients
-
Wagstaff AJ, Plosker GL, Balfour J. Inactivated hepatitis A vaccine (HM175 strain): a preliminary review of its immunogenicity, protective potential and tolerability in at-risk patients. Clin Immunother 1996; 6: 68-88
-
(1996)
Clin. Immunother
, vol.6
, pp. 68-88
-
-
Wagstaff, A.J.1
Plosker, G.L.2
Balfour, J.3
-
14
-
-
0031811589
-
Two-year review of hepatitis A vaccine safety: Data from the vaccine adverse event reporting system (VAERS)
-
Niu MT, Salive M, Krueger N, Ellenberg SS. Two-year review of hepatitis A vaccine safety: data from the vaccine adverse event reporting system (VAERS). Clin Infect Dis 1998; 26: 1475-1476
-
(1998)
Clin. Infect Dis
, vol.26
, pp. 1475-1476
-
-
Niu, M.T.1
Salive, M.2
Krueger, N.3
Ellenberg, S.S.4
-
15
-
-
0029901455
-
Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other travellers vaccines with the immune response
-
Bienzle U, Bock HL, Kruppenbacher JP et al. Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other travellers vaccines with the immune response. Vaccine 1996; 14: 501-505
-
(1996)
Vaccine
, vol.14
, pp. 501-505
-
-
Bienzle, U.1
Bock, H.L.2
Kruppenbacher, J.P.3
-
16
-
-
0032966129
-
Protective effect of hepatitis B vaccine in chronic hemodialysis patients
-
Miller E, Alter MJ, Tokars JI. Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis 1999; 33: 356-360
-
(1999)
Am. J. Kidney Dis
, vol.33
, pp. 356-360
-
-
Miller, E.1
Alter, M.J.2
Tokars, J.I.3
-
18
-
-
0033765040
-
A randmomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients
-
Charest AF, McDougall J, Goldstein MB. A randmomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 2000; 36: 976-982
-
(2000)
Am. J. Kidney Dis
, vol.36
, pp. 976-982
-
-
Charest, A.F.1
McDougall, J.2
Goldstein, M.B.3
-
19
-
-
0021204123
-
Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy
-
Stevens CE, Alter HJ, Taylor PE et al. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med 1984; 311: 496-501
-
(1984)
N. Engl. J. Med
, vol.311
, pp. 496-501
-
-
Stevens, C.E.1
Alter, H.J.2
Taylor, P.E.3
-
20
-
-
0029836718
-
A study to assess the immunogenicity, reactogenicity and safety of hepatitis A vaccine administered subcutaneously to patients with congenital coagulation disorders
-
Zuckerman JN, Moore S, Smith J et al. A study to assess the immunogenicity, reactogenicity and safety of hepatitis A vaccine administered subcutaneously to patients with congenital coagulation disorders. Haemophilia 1996; 2: 235-239
-
(1996)
Haemophilia
, vol.2
, pp. 235-239
-
-
Zuckerman, J.N.1
Moore, S.2
Smith, J.3
-
21
-
-
0034106762
-
Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia
-
Ragni MV, Lusher JM, Koerper MA, Manco-Johnson M, Krause DS. Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia. Haemophilia 2000; 6: 98-103
-
(2000)
Haemophilia
, vol.6
, pp. 98-103
-
-
Ragni, M.V.1
Lusher, J.M.2
Koerper, M.A.3
Manco-Johnson, M.4
Krause, D.S.5
-
22
-
-
0031915859
-
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
-
Keeffe EB, Iwarson S, McMahon BJ et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998; 27: 881-886
-
(1998)
Hepatology
, vol.27
, pp. 881-886
-
-
Keeffe, E.B.1
Iwarson, S.2
McMahon, B.J.3
-
23
-
-
0032712249
-
Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recients
-
Stark K, Günther M, Neuhaus R et al. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant reci ents. J Infect Dis 1999; 180: 2014-2017
-
(1999)
J. Infect Dis
, vol.180
, pp. 2014-2017
-
-
Stark, K.1
Günther, M.2
Neuhaus, R.3
|